Skip to main content
NCBI home page
The EMBO Journal logoLink to The EMBO Journal
. 1991 Jun;10(6):1399–1406. doi: 10.1002/j.1460-2075.1991.tb07660.x

Silencing and trans-activation of the mouse IL-2 gene in Xenopus oocytes by proteins from resting and mitogen-induced primary T-lymphocytes.

A Mouzaki 1, R Weil 1, L Muster 1, D Rungger 1
PMCID: PMC452801  PMID: 2026141

Abstract

The Xenopus oocyte system was used to test functionally, putative trans-active elements involved in the transcriptional control of the mouse interleukin-2 (IL-2) gene in resting and mitogen-induced primary T-lymphocytes. The IL-2 gene injected into the oocyte is active over a wide range of DNA concentrations. This basal activity is silenced by the addition of protein extracts from G0-arrested spleen cells. Extracts from 8 h-stimulated spleen cells do not silence but moderately increase transcription over basal level. When IL-2 transcription is silenced first by an injection of extract from resting spleen cells, the addition of proteins from stimulated cells results in a strong increase in transcription (derepression). Use of proteins from purified splenic T-lymphocytes shows that both silencer(s) and activator(s) are contributed by these cells. Extracts from control tissues have neither a silencing nor stimulatory effect. None of the proteins tested affects the activities of co-injected control genes. Injections with IL-2 promoter mutants indicate that the main target sequence of the silencing and activating factors is a purine region (Pu-box) lying between positions -261 and -292 upstream of the IL-2 gene. Bandshift assays show differential binding of the Pu-box with proteins from resting or activated T-cells.

Full text

PDF
1399

Images in this article

1400Image
on p.1400
1400Image
on p.1400
1401Image
on p.1401
1402Image
on p.1402
1402Image
on p.1402
1403Image
on p.1403

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cochran M. D., Weissmann C. Modular structure of the beta-globin and the TK promoters. EMBO J. 1984 Nov;3(11):2453–2459. doi: 10.1002/j.1460-2075.1984.tb02155.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Crabtree G. R. Contingent genetic regulatory events in T lymphocyte activation. Science. 1989 Jan 20;243(4889):355–361. doi: 10.1126/science.2783497. [DOI] [PubMed] [Google Scholar]
  3. Degrave W., Simons G., Devos R., Plaetinck G., Remaut E., Tavernier J., Fiers W. Cloning and structure of a mouse interleukin-2 chromosomal gene. Mol Biol Rep. 1986;11(1):57–61. doi: 10.1007/BF00417597. [DOI] [PubMed] [Google Scholar]
  4. Dierks P., van Ooyen A., Cochran M. D., Dobkin C., Reiser J., Weissmann C. Three regions upstream from the cap site are required for efficient and accurate transcription of the rabbit beta-globin gene in mouse 3T6 cells. Cell. 1983 Mar;32(3):695–706. doi: 10.1016/0092-8674(83)90055-7. [DOI] [PubMed] [Google Scholar]
  5. Dreano M., Brochot J., Myers A., Cheng-Meyer C., Rungger D., Voellmy R., Bromley P. High-level, heat-regulated synthesis of proteins in eukaryotic cells. Gene. 1986;49(1):1–8. doi: 10.1016/0378-1119(86)90380-x. [DOI] [PubMed] [Google Scholar]
  6. Emmel E. A., Verweij C. L., Durand D. B., Higgins K. M., Lacy E., Crabtree G. R. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science. 1989 Dec 22;246(4937):1617–1620. doi: 10.1126/science.2595372. [DOI] [PubMed] [Google Scholar]
  7. Fujita T., Shibuya H., Ohashi T., Yamanishi K., Taniguchi T. Regulation of human interleukin-2 gene: functional DNA sequences in the 5' flanking region for the gene expression in activated T lymphocytes. Cell. 1986 Aug 1;46(3):401–405. doi: 10.1016/0092-8674(86)90660-4. [DOI] [PubMed] [Google Scholar]
  8. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982 Sep;2(9):1044–1051. doi: 10.1128/mcb.2.9.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gulino A., Vacca A., Farina A. R., Screpanti I., Maroder M., Gismondi A., Santoni A., Frati L., Luethy J. D., Holbrook N. J. T-cell restricted and unrestricted expression of transfected human interleukin-2 gene: phorbol ester- and calcium-inducible versus constitutive expression. Biochim Biophys Acta. 1990 Sep 10;1087(1):7–17. doi: 10.1016/0167-4781(90)90114-h. [DOI] [PubMed] [Google Scholar]
  10. Hutchings P., Marshall-Clarke S., Cooke A. Suppression of induced erythrocyte autoantibodies is dependent on Lyt 1 cells. Immunology. 1985 Oct;56(2):269–273. [PMC free article] [PubMed] [Google Scholar]
  11. Kamps M. P., Corcoran L., LeBowitz J. H., Baltimore D. The promoter of the human interleukin-2 gene contains two octamer-binding sites and is partially activated by the expression of Oct-2. Mol Cell Biol. 1990 Oct;10(10):5464–5472. doi: 10.1128/mcb.10.10.5464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Khandjian E. W. UV crosslinking of RNA to nylon membrane enhances hybridization signals. Mol Biol Rep. 1986;11(2):107–115. doi: 10.1007/BF00364822. [DOI] [PubMed] [Google Scholar]
  13. Mous J., Stunnenberg H., Georgiev O., Birnstiel M. L. Stimulation of sea urchin H2B histone gene transcription by a chromatin-associated protein fraction depends on gene sequences downstream of the transcription start site. Mol Cell Biol. 1985 Oct;5(10):2764–2769. doi: 10.1128/mcb.5.10.2764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mårtensson I. L., Leanderson T. Regulation of interleukin 2 gene expression: discrepancy between enhancer activity and endogenous gene expression. Eur J Immunol. 1989 Jan;19(1):145–149. doi: 10.1002/eji.1830190123. [DOI] [PubMed] [Google Scholar]
  15. Nabel G. J., Gorka C., Baltimore D. T-cell-specific expression of interleukin 2: evidence for a negative regulatory site. Proc Natl Acad Sci U S A. 1988 May;85(9):2934–2938. doi: 10.1073/pnas.85.9.2934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Novak T. J., White P. M., Rothenberg E. V. Regulatory anatomy of the murine interleukin-2 gene. Nucleic Acids Res. 1990 Aug 11;18(15):4523–4533. doi: 10.1093/nar/18.15.4523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Randak C., Brabletz T., Hergenröther M., Sobotta I., Serfling E. Cyclosporin A suppresses the expression of the interleukin 2 gene by inhibiting the binding of lymphocyte-specific factors to the IL-2 enhancer. EMBO J. 1990 Aug;9(8):2529–2536. doi: 10.1002/j.1460-2075.1990.tb07433.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rungger D., Muster L., Boeck R., Nichols A. Tissue-specific trans-activation of the rabbit beta-globin promoter in Xenopus oocytes. Differentiation. 1990 Jul;44(1):8–17. doi: 10.1111/j.1432-0436.1990.tb00531.x. [DOI] [PubMed] [Google Scholar]
  19. Schreiber E., Matthias P., Müller M. M., Schaffner W. Identification of a novel lymphoid specific octamer binding protein (OTF-2B) by proteolytic clipping bandshift assay (PCBA). EMBO J. 1988 Dec 20;7(13):4221–4229. doi: 10.1002/j.1460-2075.1988.tb03319.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Schreiber S. L. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science. 1991 Jan 18;251(4991):283–287. doi: 10.1126/science.1702904. [DOI] [PubMed] [Google Scholar]
  21. Serfling E., Barthelmäs R., Pfeuffer I., Schenk B., Zarius S., Swoboda R., Mercurio F., Karin M. Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes. EMBO J. 1989 Feb;8(2):465–473. doi: 10.1002/j.1460-2075.1989.tb03399.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Shaw J. P., Utz P. J., Durand D. B., Toole J. J., Emmel E. A., Crabtree G. R. Identification of a putative regulator of early T cell activation genes. Science. 1988 Jul 8;241(4862):202–205. doi: 10.1126/science.3260404. [DOI] [PubMed] [Google Scholar]
  23. Shibuya H., Taniguchi T. Identification of multiple cis-elements and trans-acting factors involved in the induced expression of human IL-2 gene. Nucleic Acids Res. 1989 Nov 25;17(22):9173–9184. doi: 10.1093/nar/17.22.9173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Weil P. A., Luse D. S., Segall J., Roeder R. G. Selective and accurate initiation of transcription at the Ad2 major late promotor in a soluble system dependent on purified RNA polymerase II and DNA. Cell. 1979 Oct;18(2):469–484. doi: 10.1016/0092-8674(79)90065-5. [DOI] [PubMed] [Google Scholar]
  25. Wigley P. L., Wells J. R. H5 gene specific trans-activation by nuclear extracts from avian erythroid cells. Mol Cell Biol. 1987 Oct;7(10):3853–3856. doi: 10.1128/mcb.7.10.3853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Williams T. M., Eisenberg L., Burlein J. E., Norris C. A., Pancer S., Yao D., Burger S., Kamoun M., Kant J. A. Two regions within the human IL-2 gene promoter are important for inducible IL-2 expression. J Immunol. 1988 Jul 15;141(2):662–666. [PubMed] [Google Scholar]
  27. Wu C., Wilson S., Walker B., Dawid I., Paisley T., Zimarino V., Ueda H. Purification and properties of Drosophila heat shock activator protein. Science. 1987 Nov 27;238(4831):1247–1253. doi: 10.1126/science.3685975. [DOI] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES